Challenging Problems… Insightful Answers

Better ‘insight’… the ability to clearly understand, model and predict.

Discovery Platform

Verseon’s Drug Design Automation (DDA^TM) platform consists of patent-protected in silico design technology seamlessly integrated with state of the art compound synthesis and bioassays. The DDA^TM platform delivers unprecedented accuracy, reliability and scalability in drug discovery.

Internal Pipeline

Verseon’s internal discovery program is initially focusing on the development of promising preclinical candidates for well-validated disease targets in the areas of central nervous system and cardiovascular disorders with the intent to out-license to pharmaceutical partners.

For external discovery collaborations, please see our business development area.